| Product Code: ETC9973802 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Summon Dutta | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Pleural Effusion Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Pleural Effusion Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Pleural Effusion Market - Industry Life Cycle |
3.4 United States (US) Pleural Effusion Market - Porter's Five Forces |
3.5 United States (US) Pleural Effusion Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 United States (US) Pleural Effusion Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.7 United States (US) Pleural Effusion Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 United States (US) Pleural Effusion Market Revenues & Volume Share, By End-Users, 2021 & 2031F |
3.9 United States (US) Pleural Effusion Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Pleural Effusion Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of respiratory diseases such as pneumonia, tuberculosis, and lung cancer leading to pleural effusion |
4.2.2 Growing aging population in the United States, as older individuals are more prone to developing pleural effusion |
4.2.3 Advancements in diagnostic technologies and treatment options for pleural effusion |
4.3 Market Restraints |
4.3.1 High cost associated with diagnostic procedures and treatment of pleural effusion |
4.3.2 Limited awareness among healthcare professionals and patients about pleural effusion, leading to underdiagnosis and undertreatment |
4.3.3 Stringent regulatory requirements for approval of pleural effusion treatment devices and medications |
5 United States (US) Pleural Effusion Market Trends |
6 United States (US) Pleural Effusion Market, By Types |
6.1 United States (US) Pleural Effusion Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Pleural Effusion Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 United States (US) Pleural Effusion Market Revenues & Volume, By Transudative, 2021- 2031F |
6.1.4 United States (US) Pleural Effusion Market Revenues & Volume, By Exudative, 2021- 2031F |
6.1.5 United States (US) Pleural Effusion Market Revenues & Volume, By Others, 2021- 2031F |
6.2 United States (US) Pleural Effusion Market, By Treatment |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Pleural Effusion Market Revenues & Volume, By Surgery, 2021- 2031F |
6.2.3 United States (US) Pleural Effusion Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.4 United States (US) Pleural Effusion Market Revenues & Volume, By Others, 2021- 2031F |
6.3 United States (US) Pleural Effusion Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Pleural Effusion Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 United States (US) Pleural Effusion Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.3.4 United States (US) Pleural Effusion Market Revenues & Volume, By Others, 2021- 2031F |
6.4 United States (US) Pleural Effusion Market, By End-Users |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Pleural Effusion Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 United States (US) Pleural Effusion Market Revenues & Volume, By Homecare, 2021- 2031F |
6.4.4 United States (US) Pleural Effusion Market Revenues & Volume, By Speciality Centres, 2021- 2031F |
6.4.5 United States (US) Pleural Effusion Market Revenues & Volume, By Others, 2021- 2031F |
6.5 United States (US) Pleural Effusion Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Pleural Effusion Market Revenues & Volume, By Hospital Pharmacy, 2021- 2031F |
6.5.3 United States (US) Pleural Effusion Market Revenues & Volume, By Online Pharmacy, 2021- 2031F |
6.5.4 United States (US) Pleural Effusion Market Revenues & Volume, By Retail Pharmacy, 2021- 2031F |
7 United States (US) Pleural Effusion Market Import-Export Trade Statistics |
7.1 United States (US) Pleural Effusion Market Export to Major Countries |
7.2 United States (US) Pleural Effusion Market Imports from Major Countries |
8 United States (US) Pleural Effusion Market Key Performance Indicators |
8.1 Average time to diagnosis of pleural effusion |
8.2 Number of healthcare facilities offering specialized care for pleural effusion |
8.3 Patient survival rate post-treatment for pleural effusion |
9 United States (US) Pleural Effusion Market - Opportunity Assessment |
9.1 United States (US) Pleural Effusion Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 United States (US) Pleural Effusion Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.3 United States (US) Pleural Effusion Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 United States (US) Pleural Effusion Market Opportunity Assessment, By End-Users, 2021 & 2031F |
9.5 United States (US) Pleural Effusion Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Pleural Effusion Market - Competitive Landscape |
10.1 United States (US) Pleural Effusion Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Pleural Effusion Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here